True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
biogen, biotech stock review

Biotech’s Turning Up…

Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News. We keep telling investors...

Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...

We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...
Internet Stock Review

What We’re Watching.

“Biotech, Beverages and Bears - Oh My!” — Daniel K. McMahon

Medtech Incubator in Final Stages of Launch.

TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner...
Dyadic

Investor Presentation Slides From Dyadic (DYA) $6.40.

Really, How Do We Do It? Live Short Term Chart
Mitesco

Healthcare Incubators and Wearable Devices.

Originally published August 22, 2019 The Global Wearable Devices Market is expected to exceed more than $51.50 billion by...
biotech stock review

Innovus (INNV) Gains 75% in Past Week.

After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU). Click...

Adding Accelerize (ACLZ) $0.05 to Watch List.

Light Research, But This Looks Like a Bargain at First Blush. CFN Media is now a publicly-traded company...

Short Squeeze Alert.

Internet Stock Review Adds Ebix (EBIX) $39 to Watch List. Short Squeeze Coming? Price Target $110.

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!